Scientists will soon test whether livers from a gene-edited pig could treat people with sudden liver failure – by temporarily filtering their blood so their own organ can rest and maybe heal.
The first-of-its-kind clinical trial has been cleared by the US Food and Drug Administration (FDA), according to pig producer eGenesis, which announced the step Tuesday with its partner OrganOx.
